Balchem Corporation is a global leader in specialty performance ingredients, utilizing proprietary microencapsulation and chelation technologies to deliver high-value solutions across various industries. The company operates through three main business segments. The Human Nutrition and Health segment supplies customized food and beverage ingredient systems, including flavor delivery systems, spray-dried emulsified powders, and essential nutrients like choline and vitamin K2, catering to the food, supplement, and pharmaceutical sectors. The Animal Nutrition and Health segment focuses on nutritional products derived from microencapsulation and chelation technologies, alongside basic choline chloride, to enhance livestock health and productivity. The Specialty Products segment primarily provides ethylene oxide for the medical device sterilization industry, as well as plant nutrition products. By leveraging its advanced delivery technologies, Balchem protects active ingredients from degradation, ensuring controlled release and improved efficacy. The company's strategic acquisitions, such as Kappa Bioscience and Bergstrom Nutrition, have further expanded its portfolio in science-backed human and animal nutrition, solidifying its competitive position in the specialty chemicals and ingredients market.
